Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 271 entries
Sorted by: Best Match Show Resources per page
Biomarkers in kidney transplantation: From bench to bedside.

World journal of nephrology

Townamchai N, Eiam-Ong S.
PMID: 26558185
World J Nephrol. 2015 Nov 06;4(5):487-91. doi: 10.5527/wjn.v4.i5.487.

Immunosuppressive drug level monitoring and serum creatinine are widely used for kidney transplantation (KT) monitoring. Monitoring of drug level is not the direct measurement of the immune response while the rising of creatinine is too late for detection of...

Cite
Townamchai N, Eiam-Ong S. Biomarkers in kidney transplantation: From bench to bedside. World J Nephrol. 2015;4(5):487-91doi: 10.5527/wjn.v4.i5.487.
Townamchai, N., & Eiam-Ong, S. (2015). Biomarkers in kidney transplantation: From bench to bedside. World journal of nephrology, 4(5), 487-91. https://doi.org/10.5527/wjn.v4.i5.487
Townamchai, Natavudh, and Eiam-Ong, Somchai. "Biomarkers in kidney transplantation: From bench to bedside." World journal of nephrology vol. 4,5 (2015): 487-91. doi: https://doi.org/10.5527/wjn.v4.i5.487
Townamchai N, Eiam-Ong S. Biomarkers in kidney transplantation: From bench to bedside. World J Nephrol. 2015 Nov 06;4(5):487-91. doi: 10.5527/wjn.v4.i5.487. PMID: 26558185; PMCID: PMC4635368.
Copy Download .nbib Format: NLM
Pre-treatment considerations in childhood hypertension due to chronic kidney disease.

World journal of nephrology

Olowu WA.
PMID: 26558187
World J Nephrol. 2015 Nov 06;4(5):500-10. doi: 10.5527/wjn.v4.i5.500.

Hypertension (HTN) develops very early in childhood chronic kidney disease (CKD). It is linked with rapid progression of kidney disease, increased morbidity and mortality hence the imperative to start anti-hypertensive medication when blood pressure (BP) is persistently > 90(th)...

Cite
Olowu WA. Pre-treatment considerations in childhood hypertension due to chronic kidney disease. World J Nephrol. 2015;4(5):500-10doi: 10.5527/wjn.v4.i5.500.
Olowu, W. A. (2015). Pre-treatment considerations in childhood hypertension due to chronic kidney disease. World journal of nephrology, 4(5), 500-10. https://doi.org/10.5527/wjn.v4.i5.500
Olowu, Wasiu Adekunle. "Pre-treatment considerations in childhood hypertension due to chronic kidney disease." World journal of nephrology vol. 4,5 (2015): 500-10. doi: https://doi.org/10.5527/wjn.v4.i5.500
Olowu WA. Pre-treatment considerations in childhood hypertension due to chronic kidney disease. World J Nephrol. 2015 Nov 06;4(5):500-10. doi: 10.5527/wjn.v4.i5.500. PMID: 26558187; PMCID: PMC4635370.
Copy Download .nbib Format: NLM
Lupus-associated thrombotic thrombocytopenic purpura-like microangiopathy.

World journal of nephrology

Blum D, Blake G.
PMID: 26558190
World J Nephrol. 2015 Nov 06;4(5):528-31. doi: 10.5527/wjn.v4.i5.528.

Recently reported cases of lupus complicated by a thrombotic thrombocytopenic purpura (TTP)-like syndrome suggest a survival benefit to early treatment with plasma exchange. The following is a report of the eighth such case in the last ten years. A...

Cite
Blum D, Blake G. Lupus-associated thrombotic thrombocytopenic purpura-like microangiopathy. World J Nephrol. 2015;4(5):528-31doi: 10.5527/wjn.v4.i5.528.
Blum, D., & Blake, G. (2015). Lupus-associated thrombotic thrombocytopenic purpura-like microangiopathy. World journal of nephrology, 4(5), 528-31. https://doi.org/10.5527/wjn.v4.i5.528
Blum, Daniel, and Blake, Geoffrey. "Lupus-associated thrombotic thrombocytopenic purpura-like microangiopathy." World journal of nephrology vol. 4,5 (2015): 528-31. doi: https://doi.org/10.5527/wjn.v4.i5.528
Blum D, Blake G. Lupus-associated thrombotic thrombocytopenic purpura-like microangiopathy. World J Nephrol. 2015 Nov 06;4(5):528-31. doi: 10.5527/wjn.v4.i5.528. PMID: 26558190; PMCID: PMC4635373.
Copy Download .nbib Format: NLM
Prevalence and outcome of acute kidney injury, as defined by the new Kidney Disease Improving Global Outcomes guideline, in very low birth weight infants.

World journal of nephrology

Al Malla M, Varghese NV, AlAbdullatif M, Narchi H, Khassawneh M.
PMID: 28948160
World J Nephrol. 2017 Sep 06;6(5):229-235. doi: 10.5527/wjn.v6.i5.229.

AIM: To evaluate the prevalence, risk factors and outcome of acute kidney injury (AKI) in very low birth weight (VLBW) infants.METHODS: In this retrospective study of VLBW infants, we analyzed the prevalence of AKI, as defined by changes in...

Cite
Al Malla M, Varghese NV, AlAbdullatif M, et al. Prevalence and outcome of acute kidney injury, as defined by the new Kidney Disease Improving Global Outcomes guideline, in very low birth weight infants. World J Nephrol. 2017;6(5):229-235doi: 10.5527/wjn.v6.i5.229.
Al Malla, M., Varghese, N. V., AlAbdullatif, M., Narchi, H., & Khassawneh, M. (2017). Prevalence and outcome of acute kidney injury, as defined by the new Kidney Disease Improving Global Outcomes guideline, in very low birth weight infants. World journal of nephrology, 6(5), 229-235. https://doi.org/10.5527/wjn.v6.i5.229
Al Malla, Maisa, et al. "Prevalence and outcome of acute kidney injury, as defined by the new Kidney Disease Improving Global Outcomes guideline, in very low birth weight infants." World journal of nephrology vol. 6,5 (2017): 229-235. doi: https://doi.org/10.5527/wjn.v6.i5.229
Al Malla M, Varghese NV, AlAbdullatif M, Narchi H, Khassawneh M. Prevalence and outcome of acute kidney injury, as defined by the new Kidney Disease Improving Global Outcomes guideline, in very low birth weight infants. World J Nephrol. 2017 Sep 06;6(5):229-235. doi: 10.5527/wjn.v6.i5.229. PMID: 28948160; PMCID: PMC5592427.
Copy Download .nbib Format: NLM
Complement activation in progressive renal disease.

World journal of nephrology

Fearn A, Sheerin NS.
PMID: 25664245
World J Nephrol. 2015 Feb 06;4(1):31-40. doi: 10.5527/wjn.v4.i1.31.

Chronic kidney disease (CKD) is common and the cause of significant morbidity and mortality. The replacement of functioning nephrons by fibrosis is characteristic of progressive disease. The pathways that lead to fibrosis are not fully understood, although chronic non-resolving...

Cite
Fearn A, Sheerin NS. Complement activation in progressive renal disease. World J Nephrol. 2015;4(1):31-40doi: 10.5527/wjn.v4.i1.31.
Fearn, A., & Sheerin, N. S. (2015). Complement activation in progressive renal disease. World journal of nephrology, 4(1), 31-40. https://doi.org/10.5527/wjn.v4.i1.31
Fearn, Amy, and Sheerin, Neil Stephen. "Complement activation in progressive renal disease." World journal of nephrology vol. 4,1 (2015): 31-40. doi: https://doi.org/10.5527/wjn.v4.i1.31
Fearn A, Sheerin NS. Complement activation in progressive renal disease. World J Nephrol. 2015 Feb 06;4(1):31-40. doi: 10.5527/wjn.v4.i1.31. PMID: 25664245; PMCID: PMC4317626.
Copy Download .nbib Format: NLM
Increasing the use of biocompatible, glucose-free peritoneal dialysis solutions.

World journal of nephrology

Qayyum A, Oei EL, Paudel K, Fan SL.
PMID: 25664250
World J Nephrol. 2015 Feb 06;4(1):92-7. doi: 10.5527/wjn.v4.i1.92.

A major concern inhibiting some clinicians from embracing peritoneal dialysis (PD) as the preferred first modality of dialysis is the effects of PD solutions on the peritoneal membrane. These anatomical and functional changes predispose to complications like peritonitis, encapsulating...

Cite
Qayyum A, Oei EL, Paudel K, et al. Increasing the use of biocompatible, glucose-free peritoneal dialysis solutions. World J Nephrol. 2015;4(1):92-7doi: 10.5527/wjn.v4.i1.92.
Qayyum, A., Oei, E. L., Paudel, K., & Fan, S. L. (2015). Increasing the use of biocompatible, glucose-free peritoneal dialysis solutions. World journal of nephrology, 4(1), 92-7. https://doi.org/10.5527/wjn.v4.i1.92
Qayyum, Ahad, et al. "Increasing the use of biocompatible, glucose-free peritoneal dialysis solutions." World journal of nephrology vol. 4,1 (2015): 92-7. doi: https://doi.org/10.5527/wjn.v4.i1.92
Qayyum A, Oei EL, Paudel K, Fan SL. Increasing the use of biocompatible, glucose-free peritoneal dialysis solutions. World J Nephrol. 2015 Feb 06;4(1):92-7. doi: 10.5527/wjn.v4.i1.92. PMID: 25664250; PMCID: PMC4317632.
Copy Download .nbib Format: NLM
Evidence-based medicine: An update on treatments for peritoneal dialysis-related peritonitis.

World journal of nephrology

Barretti P, Doles JV, Pinotti DG, El Dib RP.
PMID: 25949943
World J Nephrol. 2015 May 06;4(2):287-94. doi: 10.5527/wjn.v4.i2.287.

Peritonitis continues to be a major complication of peritoneal dialysis (PD), and adequate treatment is crucial for a favorable outcome. There is no consensus regarding the optimal therapeutic regimen, and few prospective controlled studies have been published. The objective...

Cite
Barretti P, Doles JV, Pinotti DG, et al. Evidence-based medicine: An update on treatments for peritoneal dialysis-related peritonitis. World J Nephrol. 2015;4(2):287-94doi: 10.5527/wjn.v4.i2.287.
Barretti, P., Doles, J. V., Pinotti, D. G., & El Dib, R. P. (2015). Evidence-based medicine: An update on treatments for peritoneal dialysis-related peritonitis. World journal of nephrology, 4(2), 287-94. https://doi.org/10.5527/wjn.v4.i2.287
Barretti, Pasqual, et al. "Evidence-based medicine: An update on treatments for peritoneal dialysis-related peritonitis." World journal of nephrology vol. 4,2 (2015): 287-94. doi: https://doi.org/10.5527/wjn.v4.i2.287
Barretti P, Doles JV, Pinotti DG, El Dib RP. Evidence-based medicine: An update on treatments for peritoneal dialysis-related peritonitis. World J Nephrol. 2015 May 06;4(2):287-94. doi: 10.5527/wjn.v4.i2.287. PMID: 25949943; PMCID: PMC4419139.
Copy Download .nbib Format: NLM
Pediatric lupus nephritis: Management update.

World journal of nephrology

Sinha R, Raut S.
PMID: 24868499
World J Nephrol. 2014 May 06;3(2):16-23. doi: 10.5527/wjn.v3.i2.16.

Childhood-onset systemic lupus erythematosus (cSLE) is a severe multisystem autoimmune disease. Renal involvement occurs in the majority of cSLE patients and is often fatal. Renal biopsy is an important investigation in the management of lupus nephritis. Treatment of renal...

Cite
Sinha R, Raut S. Pediatric lupus nephritis: Management update. World J Nephrol. 2014;3(2):16-23doi: 10.5527/wjn.v3.i2.16.
Sinha, R., & Raut, S. (2014). Pediatric lupus nephritis: Management update. World journal of nephrology, 3(2), 16-23. https://doi.org/10.5527/wjn.v3.i2.16
Sinha, Rajiv, and Raut, Sumantra. "Pediatric lupus nephritis: Management update." World journal of nephrology vol. 3,2 (2014): 16-23. doi: https://doi.org/10.5527/wjn.v3.i2.16
Sinha R, Raut S. Pediatric lupus nephritis: Management update. World J Nephrol. 2014 May 06;3(2):16-23. doi: 10.5527/wjn.v3.i2.16. PMID: 24868499; PMCID: PMC4023399.
Copy Download .nbib Format: NLM
Gait speed and hospitalization among ambulatory hemodialysis patients: USRDS special study data.

World journal of nephrology

Kutner NG, Zhang R, Huang Y, Wasse H.
PMID: 25332901
World J Nephrol. 2014 Aug 06;3(3):101-6. doi: 10.5527/wjn.v3.i3.101.

AIM: To assess the association of measured gait speed with hemodialysis (HD) patients' hospitalization, in conjunction with, and apart from, recent fall history.METHODS: Gait speed was measured by a standard protocol and falls during the past 12 mo were...

Cite
Kutner NG, Zhang R, Huang Y, et al. Gait speed and hospitalization among ambulatory hemodialysis patients: USRDS special study data. World J Nephrol. 2014;3(3):101-6doi: 10.5527/wjn.v3.i3.101.
Kutner, N. G., Zhang, R., Huang, Y., & Wasse, H. (2014). Gait speed and hospitalization among ambulatory hemodialysis patients: USRDS special study data. World journal of nephrology, 3(3), 101-6. https://doi.org/10.5527/wjn.v3.i3.101
Kutner, Nancy G, et al. "Gait speed and hospitalization among ambulatory hemodialysis patients: USRDS special study data." World journal of nephrology vol. 3,3 (2014): 101-6. doi: https://doi.org/10.5527/wjn.v3.i3.101
Kutner NG, Zhang R, Huang Y, Wasse H. Gait speed and hospitalization among ambulatory hemodialysis patients: USRDS special study data. World J Nephrol. 2014 Aug 06;3(3):101-6. doi: 10.5527/wjn.v3.i3.101. PMID: 25332901; PMCID: PMC4202486.
Copy Download .nbib Format: NLM
Long-term outcome of ketoconazole and tacrolimus co-administration in kidney transplant patients.

World journal of nephrology

Khan E, Killackey M, Kumbala D, LaGuardia H, Liu YJ, Qin HZ, Alper B, Paramesh A, Buell J, Zhang R.
PMID: 25332902
World J Nephrol. 2014 Aug 06;3(3):107-13. doi: 10.5527/wjn.v3.i3.107.

AIM: To study the long-term outcome of ketoconazole and tacrolimus combination in kidney transplant recipients.METHODS: From 2006 to 2010, ketoconazole was given in 199 patients and was continued for at least 1 year or until graft failure (Group 1),...

Cite
Khan E, Killackey M, Kumbala D, et al. Long-term outcome of ketoconazole and tacrolimus co-administration in kidney transplant patients. World J Nephrol. 2014;3(3):107-13doi: 10.5527/wjn.v3.i3.107.
Khan, E., Killackey, M., Kumbala, D., LaGuardia, H., Liu, Y. J., Qin, H. Z., Alper, B., Paramesh, A., Buell, J., & Zhang, R. (2014). Long-term outcome of ketoconazole and tacrolimus co-administration in kidney transplant patients. World journal of nephrology, 3(3), 107-13. https://doi.org/10.5527/wjn.v3.i3.107
Khan, Enver, et al. "Long-term outcome of ketoconazole and tacrolimus co-administration in kidney transplant patients." World journal of nephrology vol. 3,3 (2014): 107-13. doi: https://doi.org/10.5527/wjn.v3.i3.107
Khan E, Killackey M, Kumbala D, LaGuardia H, Liu YJ, Qin HZ, Alper B, Paramesh A, Buell J, Zhang R. Long-term outcome of ketoconazole and tacrolimus co-administration in kidney transplant patients. World J Nephrol. 2014 Aug 06;3(3):107-13. doi: 10.5527/wjn.v3.i3.107. PMID: 25332902; PMCID: PMC4202487.
Copy Download .nbib Format: NLM
Hepcidin-25 negatively predicts left ventricular mass index in chronic kidney disease patients.

World journal of nephrology

Hsieh YP, Huang CH, Lee CY, Chen HL, Lin CY, Chang CC.
PMID: 24175264
World J Nephrol. 2013 May 06;2(2):38-43. doi: 10.5527/wjn.v2.i2.38.

AIM: To assess the correlation between the serum hepcidin-25 level and left ventricular mass index.METHODS: This study was a cross-sectional study conducted between March 2009 and April 2010. Demographic and biochemical data, including the serum hepcidin-25 level, were collected...

Cite
Hsieh YP, Huang CH, Lee CY, et al. Hepcidin-25 negatively predicts left ventricular mass index in chronic kidney disease patients. World J Nephrol. 2013;2(2):38-43doi: 10.5527/wjn.v2.i2.38.
Hsieh, Y. P., Huang, C. H., Lee, C. Y., Chen, H. L., Lin, C. Y., & Chang, C. C. (2013). Hepcidin-25 negatively predicts left ventricular mass index in chronic kidney disease patients. World journal of nephrology, 2(2), 38-43. https://doi.org/10.5527/wjn.v2.i2.38
Hsieh, Yao-Peng, et al. "Hepcidin-25 negatively predicts left ventricular mass index in chronic kidney disease patients." World journal of nephrology vol. 2,2 (2013): 38-43. doi: https://doi.org/10.5527/wjn.v2.i2.38
Hsieh YP, Huang CH, Lee CY, Chen HL, Lin CY, Chang CC. Hepcidin-25 negatively predicts left ventricular mass index in chronic kidney disease patients. World J Nephrol. 2013 May 06;2(2):38-43. doi: 10.5527/wjn.v2.i2.38. PMID: 24175264; PMCID: PMC3782224.
Copy Download .nbib Format: NLM
Experimental models of renal calcium stones in rodents.

World journal of nephrology

Bilbault H, Haymann JP.
PMID: 26981444
World J Nephrol. 2016 Mar 06;5(2):189-94. doi: 10.5527/wjn.v5.i2.189.

In human nephrolithiasis, most stones are containing calcium and are located within urinary cavities; they may contain monohydrate calcium oxalate, dihydrate calcium oxalate and/or calcium phosphates in various proportion. Nephrolithiasis may also be associated with nephrocalcinosis, i.e., crystal depositions...

Cite
Bilbault H, Haymann JP. Experimental models of renal calcium stones in rodents. World J Nephrol. 2016;5(2):189-94doi: 10.5527/wjn.v5.i2.189.
Bilbault, H., & Haymann, J. P. (2016). Experimental models of renal calcium stones in rodents. World journal of nephrology, 5(2), 189-94. https://doi.org/10.5527/wjn.v5.i2.189
Bilbault, Héloïse, and Haymann, Jean-Philippe. "Experimental models of renal calcium stones in rodents." World journal of nephrology vol. 5,2 (2016): 189-94. doi: https://doi.org/10.5527/wjn.v5.i2.189
Bilbault H, Haymann JP. Experimental models of renal calcium stones in rodents. World J Nephrol. 2016 Mar 06;5(2):189-94. doi: 10.5527/wjn.v5.i2.189. PMID: 26981444; PMCID: PMC4777791.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 271 entries